US-based Ayurvedic herbal brands primarily use reverse engineering for internal quality control and product standardization, which indirectly aids in meeting the US Food and Drug Administration's (FDA) regulatory and compliance requirements for dietary supplements. The FDA does not have a specific approval process for Ayurvedic products, but regulates them under the same framework as other dietary supplements.
How USA's Herbal Brands in the Ayurveda Segment Use Reverse Engineering to benchmark regulatory and compliance requirements
US-based Ayurvedic herbal brands primarily use reverse engineering for internal quality control and product standardization, which indirectly aids in meeting the US Food and Drug Administration’s (FDA) regulatory and compliance requirements for dietary supplements. The FDA does not have a specific approval process for Ayurvedic products, but regulates them under the same framework as other dietary supplements.
Ayurveda-based herbal supplement formulation service is rapidly gaining popularity in the US as consumers favour natural, preventive health options. However, a gap exists between Ayurveda’s tradition-driven, holistic approach and the FDA’s science-based DSHEA framework, which focuses on safety, standardization, accurate labelling, and controlled manufacturing. Reverse engineering methodologies helps bridge this divide by analyzing successful, US-compliant herbal products regulation to understand how traditional concepts are adapted into FDA-acceptable formats, enabling brands to develop regulatory-ready supplements from the start instead of retrofitting compliance later.[1] [2] [3]
Product Classification as the Foundation of U.S. Regulatory Compliance for Ayurvedic Products
Ayurvedic regulatory compliance requirements in the U.S. depend on how the development of herbal product is classified and the claims it makes:
- Dietary Supplements: Most capsules, tablets, powders, and churnas are regulated under DSHEA.
- Foods & Functional Beverages: Products must comply with FDA food regulations, including ingredient approvals and nutrition labelling.
- Cosmetics: Topical oils, creams, and balms may fall under cosmetic regulations if no therapeutic claims are made.
- Drugs: Any product claiming to treat, cure, mitigate, or prevent disease is classified as a drug, triggering strict clinical and FDA approval requirements.
- Reverse engineering methodologies helps brands study competitor classification strategies to identify compliant, low-risk pathways and optimize market positioning within U.S. herbal product regulation frameworks.[4] [5]
Regulatory Challenges for Ayurvedic Products in the US and the Role of Reverse Engineering
- In the US herbal brand, Ayurvedic formulation service is generally marketed as dietary supplements under Dietary Supplement Health and Education Act (DSHEA), which does not require pre-market approval but enforces strict regulatory accountability.
- This is particularly important for Ayurveda because many herbs are multi-component and unfamiliar to FDA reviewers, traditional dosing concepts must be converted into standardized daily servings, and historical use alone is insufficient without modern safety evidence.
- Reverse engineering methodologies allows brands to study compliant products to understand how others have successfully addressed these regulatory challenges.
Key Regulatory Expectations for Ayurvedic/Dietary Supplement Brands:
The key regulatory expectations that Ayurvedic and dietary supplement of herbal brands in the U.S. regulation must meet. The following table explains the purpose of each area, the relevant compliance standards, and practical actions brands take to ensure the herbal product development regulatory adherence.[6] [7]
Regulatory Area | Purpose | Compliance Focus (US Standards) | Practical Brand Action |
Ingredient Legality | Ensure all ingredients are lawful and safe | 21 CFR 190; NDI Guidance | Select compliant botanicals; avoid banned substances |
Manufacturing Compliance | Maintain quality, safety, and reproducibility | FDA cGMP (21 CFR 111) | Implement standardized manufacturing processes |
Safety Assurance | Minimize risk of toxicity, contamination, and adulteration | FDA contaminant guidelines; USP references | Test for heavy metals, microbial contamination, and purity |
Labelling Accuracy | Prevent misbranding and provide correct information | 21 CFR 101; 21 CFR 111 | Format Supplement Facts, identity statements, and serving sizes |
Claims Substantiation | Ensure claims are truthful, non-misleading, and legally defensible | DSHEA claim rules; FTC advertising standards | Use structure/function claims with proper disclaimers |
Regulatory Enforcement & Compliance Intelligence Benchmarking
- S. regulatory expectations are shaped by enforcement actions, not only written regulations.
- Ayurvedic herbal brands reverse engineer FDA warning letters, import alerts, and FTC enforcement cases related to dietary supplements.
- Brands analyze claims language, ingredient positioning, dosage expressions, and marketing practices that triggered enforcement.
- This approach helps identify high-risk claims, ingredients, and labeling patterns before product launch.
- Benchmarking against both compliant products and enforcement precedents enables proactive regulatory risk mitigation.
Reverse Engineering as a Tool for Regulatory Benchmarking:
Reverse engineering methodologies is not just about copying; it’s about decoding regulatory compliance from market-ready development of herbal products.
Process of reverse engineering:
- Analyze the ingredient composition of compliant products.
- Identify extract types and concentrations.
- Check dosage forms (capsules, tablets, powders, liquids).
- Examine labelling and claim language to ensure regulatory safety.
Benefits:
- Converts abstract regulatory requirements into actionable formulation benchmarks.
- Reduces trial-and-error, ensuring safety margins are respected.
- Helps brands match or exceed market expectations while staying compliant.
Practical example: A US Ashwagandha capsule may use standardized root extract at a specific mg/day that aligns with FDA expectations. By reverse engineering methodologies this, a new brand knows the safe dosage range and marker compounds to include.
Herbal Industry Challenges in the Ayurveda Sector:
Core Challenges:
- Natural variability: Potency changes due to season, geography, and farming practices.
- Polyherbal complexity: Multiple herbs increase consistency and interaction risks.
- Contamination sensitivity: Heavy metals, pesticides, or other contaminants can lead to recalls.
- Authentication risks: Adulteration or incorrect botanical identification.
How Reverse Engineering Helps:
- Shows how compliant brands standardize natural variability.
- Identifies marker compounds used to ensure batch consistency.
- Highlights supplier qualification and testing strategies.
- Demonstrates effective risk-mitigation and quality control practices used in the market.
Reverse Engineering as a Benchmarking & Compliance Tool for USA Herbal (Ayurvedic) Brands:
U.S. herbal brands operating in the Ayurvedic segment use reverse engineering as a strategic regulatory benchmarking tool to align with FDA regulatory and compliance requirements. The following table explains how competitor analysis is translated into actionable insights across product classification, formulation, labelling, claims, and quality systems to reduce regulatory risk and ensure market readiness. [8] [9]
Benchmarking Area | What Brands Reverse Engineer | Regulatory Objective | Compliance Standards Referenced (USA) | Practical Outcome for Ayurvedic Brands |
Product Classification | How competitor products are positioned (dietary supplement, food, cosmetic) | Avoid unintended drug classification | DSHEA 1994; FDA product classification rules | Selection of lowest-risk regulatory pathway for Ayurvedic products |
Ingredient Legality | Botanical selection, extract type, dosage levels | Ensure ingredient is lawful and safe | 21 CFR 190; NDI guidance | Reduced risk of NDI violations and import alerts |
Formulation Design | Standardization levels, excipients, delivery format | Maintain safety and reproducibility | FDA cGMP (21 CFR 111) | Scalable, audit-ready Ayurvedic formulations |
Label Structure | Supplement Facts format, identity statements | Prevent misbranding | 21 CFR 101; 21 CFR 111 | FDA-compliant labels with reduced enforcement risk |
Claims Language | Structure/function claim phrasing used by competitors | Avoid disease claims | DSHEA claim rules; FTC advertising standards | Marketable yet compliant Ayurvedic messaging |
Disclaimer Usage | Placement and wording of FDA disclaimer | Meet mandatory disclosure | DSHEA disclaimer requirements | Legally defensible structure/function claims |
Quality Control Signals | Third-party testing, cGMP certification claims | Demonstrate quality assurance | FDA cGMP; USP references | Increased regulator and retailer confidence |
Heavy Metal Controls | Competitor testing claims for lead, mercury, arsenic | Prevent adulteration violations | FDA contaminant guidance | Lower risk of recalls and FDA warning letters |
Documentation Practices | COAs, batch records, supplier qualification | Audit and inspection readiness | 21 CFR 111 documentation rules | Faster response to FDA audits and inspections |
Enforcement Intelligence | FDA warning letters and import alerts | Identify regulatory red flags | FDA enforcement database | Proactive avoidance of high-risk claims and ingredients |
Post-Market Compliance Benchmarking & Ongoing Risk Management
- U.S. dietary supplement regulation is post-market enforced, making ongoing compliance critical.
- Ayurvedic brands reverse engineer how compliant products manage:
- Adverse event reporting
- Complaint handling and corrective actions
- Label and claim updates
- Documentation and audit readiness
- Brands monitor regulatory guidance updates and enforcement trends to refine internal compliance benchmarks.
Continuous benchmarking ensures products remain market-ready, audit-ready, and enforcement-resilient over time.
Insights From FRL:
When developing their U.S. Ashwagandha capsule line, a leading U.S.-based herbal company partnered with Food Research Lab to reverse-engineer top-performing, FDA-compliant products. The process involved regulatory benchmarking competitor of herbal formulations to standardize extract potency, optimize dosage forms, and refine label claims for DSHEA compliance. Early trials revealed challenges with natural variability and polyherbal interactions, leading to inconsistent marker compound levels. FRL’s expertise in analytical profiling and formulation adjustments helped the company overcome these hurdles, ensuring scalable, audit-ready capsules that met cGMP standards, maintained safety margins, and adhered to FDA labelling and claims regulations—transforming regulatory complexity into a reproducible, market-ready product while navigating the complexities of modern herbal product regulation.
Conclusion:
Reverse engineering enables U.S. herbal brands to transform traditional herbal formulations into FDA-compliant, market-ready products while minimizing regulatory risk. Collaborations with experts like Food Research Lab provide critical regulatory benchmarking, analytical support, and formulation guidance, helping brands overcome challenges such as natural variability and polyherbal complexity, and ensuring scalable, safe, and audit-ready supplements.
Reference:
- Prakriti World. (2025, October 13). How safe are Ayurvedic products in the USA? (FDA & safety insights). https://www.prakriti-world.com/how-safety-of-ayurvedic-products-in-the-usa/ (prakriti world)
- FDA India Office Addresses Herbal and Ayurvedic Products. (2024, August 6). S. Food and Drug Administration. https://www.fda.gov/international-programs/global-perspective/fda-india-office-addresses-herbal-and-ayurvedic-products (U.S. Food and Drug Administration)
- Garg Law PLLC. (2024, August 6). FDA India Office Addresses Safety and Regulatory Issues for Herbal and Ayurvedic Products. https://garg-law.com/fda-india-office-addresses-safety-and-regulatory-issues-for-herbal-and-ayurvedic-products/ (FDA Regulatory Law Firm)
- Jordan, C. R., Harris, C. M., Miranda, M. I., Kim, D. Y., & Hellberg, R. S. (2023). Labeling compliance and online claims for Ayurvedic herbal supplements on the U.S. market associated with the purported treatment of COVID‑19. Food Control, 148, 109673. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901855/ (PMC)
- Sapoliya, N. K., & Shah, M. B. (2022). Regulations on Herbal Products in India, United States and European Union: A Review. International Journal of Drug Regulatory Affairs, 10(2), 67–72. https://www.ijdra.com/index.php/journal/article/view/528 (ResearchGate)
- eCFR — Title 21, Part 190: Dietary Supplements. (n.d.). Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-190 (ecfr)
- S. Food and Drug Administration. (n.d.). New Dietary Ingredients in Dietary Supplements — Background for Industry. https://www.fda.gov/food/new-dietary-ingredient-ndi-notification-process/new-dietary-ingredients-dietary-supplements-background-industry (U.S. Food and Drug Administration)
- S. Food and Drug Administration. (2023, February 9). New dietary ingredients in dietary supplements – Background for industry. U.S. Department of Health and Human Services. https://www.fda.gov/food/new-dietary-ingredient-ndi-notification-process/new-dietary-ingredients-dietary-supplements-background-for-industry (fda.gov)
- (n.d.). Expert insights for U.S. FDA New Dietary Ingredient (NDI) notification. https://en.reach24h.com/service/food/us-fda-new-dietary-ingredient-ndi-notification (Reach24h)
Let’s create something Innovative and Delicious together
Food Research Lab strives for excellence in new Food, Beverage and Nutraceutical Product Research and Development by offering cutting edge scientific analysis and expertise.